| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |